Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Pediatrics in Review. 1984;5:247-254.)
© 1984 American Academy of Pediatrics

This Article
Right arrow Full Text (PDF)
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

agr1-Antitrypsin Deficiency

Two hundred thousand Swedish infants were screened for agr1-antitrypsin deficiency; 125 deficient infants, as well as 51 with intermediate levels of deficiency, were found. Twenty-two of the deficient infants developed liver disease; 14 of these 22 had conjugated hyperbilirubinemia. By age 2 years, three of these 14 children, all of whom had conjugated hyperbilirubinemia, had developed cirrhosis and the rest were well. Two children with agr1-antitrypsin deficiency developed liver disease after the first year of life in association with an intercurrent illness. None of the infants with intermediate levels of deficiency developed liver disease. Eight of the children with deficiency had recurrent wheezing and one had recurrent pneumonia with cavitation.

Comment: agr1-Antitrypsin accounts for 90% of the protease inhibitory activity of serum.







HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics  Pediatrics in Review
Copyright © 1984 by the American Academy of Pediatrics.